Cagrilintide 60mg — Vial Spec, Reconstitution Math & COA

Overview of Cagrilintide 60mg Format and Laboratory Applications

A 60mg vial of cagrilintide contains a highly purified, lyophilized powder formulation of the long-acting non-selective amylin receptor agonist. This specific high-mass unit is primarily requested by academic laboratories, contract research organizations (CROs), and institutional facilities running parallel, multi-plate receptor binding assays or long-term metabolic study cohorts in rodent models. Utilizing a single 60mg lot minimizes inter-vial reconstitution variance across extensive sample matrices, ensuring consistency across long experimental timelines.

While a single 60mg unit provides significant operational efficiency for continuous automated assays, PX1 Research primary stock listings vary based on synthesis schedules and catalog demand. If an exact 60mg single-vial configuration is not actively listed in our retail inventory, researchers can review standard unit masses via our main cagrilintide product page or arrange tailored institutional batch sizes through our dedicated wholesale laboratory program. All available compounds, regardless of mass spec, are manufactured under rigorous GMP-compliant conditions and subjected to identical analytical standards across our complete catalog of research peptides.

Molecular Structure and Amylin Receptor Co-Agonism Mechanism

Cagrilintide is an acylated peptide analog engineered to function as a long-acting, non-selective agonist at calcitonin/amylin receptors, specifically targeting the AMYR1, AMYR2, and AMYR3 subtypes as well as the calcitonin receptor (CTR). In native physiological pathways, pancreatic amylin is co-secreted with insulin by beta cells, binding to central neuroreceptors within the area postrema and nucleus tractus solitarii (NTS) to modulate gastric emptying rate, postprandial nutrient absorption, and central satiety signals.

Preclinical data indicate that cagrilintide incorporates structural lipid-alkylation modifications, allowing non-covalent albumin binding in circulation. In vitro radioperfusion assays and animal study models demonstrate that this fatty acid moiety extends the biological half-life significantly compared to native amylin or early synthetic analogs. When evaluated in metabolic screening assays, cagrilintide exhibits potent signal transduction across cAMP accumulation pathways, making it a critical benchmark compound for investigating synergistic metabolic signaling alongside incretin mimetic pathways.

Reconstitution Mathematics for 60mg Reagent Mass

Accurate reconstitution of a 60mg lyophilized cake requires precise volumetric planning to achieve desired working stock concentrations without exceeding saturation limits or creating unmanageable viscosity. Investigators should select sterile, laboratory-grade Bacteriostatic Water (0.9% benzyl alcohol) or sterile PBS depending on the specific downstream assay requirements. Standard volumetric additions for a 60mg peptide payload yield the following working stock concentrations:

• Reconstitution with 1.0 mL Diluent: Yields a concentration of 60.0 mg/mL (60.0 µg/µL). This hyper-concentrated stock is suitable for high-density microplate spiking or automated nanoliter dispensing platforms. • Reconstitution with 2.0 mL Diluent: Yields a concentration of 30.0 mg/mL (30.0 µg/µL). This provides a balanced concentration for serial dilution series and general pipetting accuracy. • Reconstitution with 3.0 mL Diluent: Yields a concentration of 20.0 mg/mL (20.0 µg/µL). Ideal for routine micro-titration where larger pipetting volumes reduce percentage volumetric error.

Researchers calculating specialized molar concentrations or micro-dosing volumes for cell-culture plates should utilize our interactive reconstitution calculator to verify custom solvent volumes before unsealing lyophilized vials.

Aliquot Management and Avoiding Freeze-Thaw Degradation

High-mass peptide vials containing 60mg of active material should never be subjected to repeated freeze-thaw cycles once reconstituted. Repeated thermal transition alters tertiary peptide conformation, accelerates hydrophobic aggregation, and promotes peptide drop-out from solution. Following initial dissolution, the primary stock solution must be immediately partitioned into single-use, sterile polypropylene micro-centrifuge tubes.

To minimize head-space oxidation, aliquots should be calculated based on daily or batch usage protocols (e.g., 50 µL to 200 µL working volumes per tube). Working aliquots should be flash-frozen using liquid nitrogen or a dry ice/ethanol bath and stored at -80°C for long-term storage, or -20°C for short-term active study phases. Aliquots thawed for immediate assay execution should be maintained on wet ice (4°C) and used within 2 to 4 hours.

Analytical Quality Verification: HPLC, Mass Spectrometry, and Endotoxin Limits

To ensure reproducible experimental outcomes, every batch of cagrilintide synthesized for PX1 Research undergoes multi-point analytical verification within an accredited ISO 17025 laboratory. High-Performance Liquid Chromatography (HPLC) is employed to confirm chemical purity, ensuring every lot meets or exceeds a strict benchmark of >99.0% main-peak area purity.

Electrospray Ionization Mass Spectrometry (ESI-MS) confirms the exact molecular mass match against the theoretical sequence of cagrilintide, verifying correct amino acid assembly and lipophilic modification. Furthermore, because sub-nanogram endotoxin contamination can confound immunological and neuro-receptor cell culture assays, our high-mass formulations are routinely subjected to Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels fall strictly below standard research tolerances (<0.01 EU/µg).

Lot-Matched COA Protocols and Documentation

PX1 Research maintains a fully transparent quality assurance framework. Every shipment of research compounds is associated with a specific, lot-matched Certificate of Analysis (COA). The COA provides non-redacted raw chromatographic data, MS spectral overlays, synthesis date, batch purity percentages, and physical appearance assessments.

Principal investigators and quality assurance officers can download authentic, batch-verified documentation directly via our public COA verification hub. Matching the physical vial lot number printed on the product label with the digital certificate ensures total traceability and eliminates batch-to-batch ambiguity in published literature.

Comparative Analysis: Cagrilintide vs. Incretin and Amylin Class Peptides

In metabolic and endocrine preclinical literature, cagrilintide is frequently investigated alongside or in combination with other metabolic receptor agonists to observe co-signaling additive effects. Understanding the distinction between pure amylin analogs and dual/triple incretin agonists is critical when structuring comparative control cohorts:

While early-generation amylin research utilized compounds like pramlintide, its shorter biological half-life requires high dosing frequency in rodent models. Cagrilintide offers extended receptor binding kinetics due to its lipid acyl chain. When evaluating synergistic pathways involving both amylin and GLP-1/GIP signaling, researchers often compare cagrilintide against mono-agonists like semaglutide or dual GLP-1/GIP co-agonists like tirzepatide. Emerging multi-receptor frameworks also evaluate triple-agonist candidates such as retatrutide alongside dual-pathway amylin-incretin combinations to map downstream energy balance dynamics.

Storage and Handling Guidelines for Lyophilized and Solubilized Formulations

Lyophilized cagrilintide 60mg vials are shipped in vacuum-sealed, temperature-monitored packaging. Upon arrival at the research facility, un-reconstituted vials should be stored immediately in a desiccated freezer environment at -20°C (stable for 12–24 months) or -80°C for long-term archival storage (stable for up to 36 months). Vials must be protected from direct light exposure.

Prior to reconstitution, allow the sealed glass vial to equalize to room temperature (20°C to 25°C) for approximately 30–45 minutes. Opening a cold vial in a ambient humidity room can cause atmospheric moisture to condense onto the lyophilized cake, leading to premature peptide hydrolysis. Diluents should be added gently down the glass wall of the vial, followed by gentle swirling. Never vortex high-mass peptide solutions, as mechanical shear forces cause denaturing and foam formation.

Selecting Mass Formulations: High-Mass 60mg vs Standard Research Vials

Determining whether to utilize a high-mass 60mg vial format versus standard single-digit milligram vials (such as 5mg or 10mg) depends primarily on scale, automation, and budget efficiency. High-throughput screening (HTS) laboratories using liquid handling robotics benefit from 60mg reconstitutions because single large volume reservoirs reduce dead-volume waste and instrument calibration cycles.

Conversely, smaller pilot studies or exploratory in vitro binding assays may prefer 5mg unit sizes to minimize long-term freezer storage footprints and avoid multi-month solution degradation risks. Research teams evaluating high-volume requirements across extensive assay matrices can explore bulk institutional pricing options on our wholesale center or review detailed pharmacological data in our peptide research hub.